Source: Eur Respir J, 50 (4) 1701209; 10.1183/13993003.01209-2017
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ganesh Raghu. Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years. Eur Respir J, 50 (4) 1701209; 10.1183/13993003.01209-2017

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences Source: Eur Respir Rev 2015; 24: 420-427 Year: 2015 Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Source: International Congress 2015 – Treatment of IPF Year: 2015 Staging of idiopathic pulmonary fibrosis: past, present and future Source: Eur Respir Rev 2014; 23:220-224 Year: 2014 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 Idiopathic pulmonary fibrosis trials: recommendations for the jury Source: Eur Respir J 2011; 38: 1002-1004 Year: 2011 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020 Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 ERJ October Podcast: Lessons from IPF clinical trials over the past 25 years Source: Eur Respir J, 50 (4) 17E5004; 10.1183/13993003.E5004-2017 Year: 2017 Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey Source: Eur Respir Rev 2014; 23:225-230 Year: 2014 What have we learned from basic science studies on idiopathic pulmonary fibrosis? Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019 Year: 2019 Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 53 (3) 1800663; 10.1183/13993003.00663-2018 Year: 2019 Idiopathic pulmonary fibrosis and pregnancy: a case controlled study Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 A registry of patients with idiopathic pulmonary fibrosis in Russia: 2-yr results and therapeutic modalities in real-life practice Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward Source: Eur Respir J 2013; 42: 1446-1448 Year: 2013